Peptidergic mechanisms of hyperthermia-evoked convulsions in rats in early postnatal ontogenesis

Neuroscience and Behavioral Physiology

Volumn 32, Issue 5, 2002, Pages 505-511

  Chepurnova, N E ^a   Ponomarenko, A A ^a   Chepurnov, S A ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Arginine vasopressin; Convulsions; Hyperthermia; Neurosecretion; PACAP

Indexed keywords

ARGIPRESSIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EPILEPTIC STATE; FEBRILE CONVULSION; GRAND MAL SEIZURE; HYPERTHERMIA; NEUROSECRETION; NONHUMAN; ONTOGENY; PEPTIDERGIC NERVOUS SYSTEM; PERINATAL PERIOD; POSTNATAL DEVELOPMENT; RAT; TONIC CLONIC SEIZURE;

ANIMALS; ANIMALS, NEWBORN; ARGININE VASOPRESSIN; BODY TEMPERATURE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEVER; NEUROPEPTIDES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; POSTNATAL CARE; RATS; RATS, INBRED STRAINS; REACTION TIME; SEIZURES, FEBRILE; TIME FACTORS;

EID: 0036709778     PISSN: 00970549     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1019807622531     Document Type: Article

References (33)

1. L. O. Badalyan, P. A. Temin, and K. Yu. Mukhin, "Febrile convulsions: diagnosis, treatment, and clinical observation," Zh. Nevropatol. Psikhiatr., 9, 97-101 (1990).
2. V. A. Karlov, Epilepsy [in Russian], Meditsina, Moscow (1990).
3. N. A. Yakovlev and T. A. Slyusar', Febrile Convulsions in Children [in Russian], Moscow (1997).
4. M. J. Aminoff, R. P. Simon, and E. Wiedemann, "The hormonal responses to generalized tonic-clonic seizures," Brain, 197, 569-578 (1984).
5. J. G. Bajorek, R. J. Lee, and P. Lomax, "Neuropeptides: anticonvulsant and convulsant mechanisms in epileptic model systems and in humans", Adv. Neurol., 44, 489-500 (1986).
6. W. A. Banks, A. J. Kastin, and A. Arimura, "Effect of spinal cord injury of the permeability and the blood-brain and blood-spinal cord barriers to the neutropin PACAP," Exp. Neurol., 151, 116-123 (1998).
7. K. L. Brunson, L. Schultz, and T. Z. Baram, "The in vivo proconvulsant effects of corticotropin releasing hormone in the developing rat are independent of ionotropic glutamate receptor activation," Brain Res. Dev. Brain Res., 111, 119-128 (1998).
8. S. A. Chepurnov, N. E. Chepurnova, and R. K. Berdiev, "Galanin controls excitability of the brain," Ann. N.Y. Acad. Sci., 11, No. 865, 547-550 (1998).
9. P. Chiodera, R. Volpi, L. Capretti, and V. Coiro, "Effects of intravenously infused pituitary adenylate cyclase-activating polypeptide on arginine pituitary adenylate cyclase-activating polypeptide on arginine vasopressin and oxytocin secretion in man," NeuroReport, 6, 1490-1492 (1995)
10. M. E. Corcoran, D. P. Cain, J. M. Finlay, and B. J. Gillis, "Vasopressin and the kindling of seizures," Life Sci., 35, 947-952 (1984).
11. D. De Weid, "Behavioral effects of intraventricularly administered vasopressin and vasopressin fragments," Life Sci., 19, 685-690 (1976).
12. 2-vasopressin, and oxytocin by brain regions," Endocrinol. Exp. {Bratislava}, 19, 29-37 (1985).
13. W. P. Gai, L. B. Geffen, and W. W. Blessing, "Galanin immunoreactive neurons in the human hypothalamus: colocalization with vasopressin-containing neurons," J. Comp. Neurol., 298, 265-280 (1990).
14. B. J. Gillis and D. P. Cain, "Kindling of the hippocampus and septum in vasopressin-deficient rats (Brattleboro strain)," Brain Res., 363, 386-389 (1986).
15. T. Gëagalo, E. E. Haic, M. T. Matuszek, P. Rekowski, G. Kupryszewski, and K. Z. Korolkiewicz, "Thermoregulatory activity of sodium nitroprusside and arginine vasopressin," Gen. Pharmacol. 26, 393-397 (1995).
16. H. Holthausen, "Febrile convulsions, medial temporal sclerosis and temporal lobe epilepsy," in: Epileptic Seizures and Syndromes, P. Wolf and John Libbey (eds.), Current Problems in Epilepsy, Vol. 10, pp. 449-467 (1994).
17. N. W. Kasting, W. L. Veale, K. E. Cooper, and K. Lederis, "Vasopressin may mediate febrile convulsions," Brain Res., 213, 327-333 (1981).
18. T. Kozicz, S. Vigh, and A. Arimura, "Axon terminals containing PACAP- and VIP-immunoreactivity form synapses with CRF-immunoreactive neurons in the dorsolateral division of the bed nucleus of the stria terminals in the rat," 767, 109-119 (1997).
19. C. C. Lai, S. Y. Wu, H. H. Lin, and N. J. Dun, "Excitatory action of pituitary adenylate cyclase activating polypeptide on rat symphathetic preganglionic neurons in vivo and in vitro," Brain Res., 748, 189-194 (1997).
20. B. Lutz-Busher, D. Monnier, and B. Koch, "Evidence for the presence of receptors for pituitary adenylate cyclase-activating polypeptide in the neurohypophysis that are positively coupled to cyclic AMP formation and neurohypophyseal hormone secretion", Neuroendocrinology, 64, 153-161 (1996).
21. Y. Masuo, J. Noguchi, S. Morita and Y. Matsumoto, "Effects of intracerebroventricular administration of pituitary adenylate cyclase-activating polypeptide (PACAP) on the motor activity and reserpine-induced hypothermia in murines", Brain Res., 700, 219-226 (1995).
22. R. S. McLachlan and D. E. Bulman, "The genetics of febrile convulsions and temporal lobe epilepsy," in: Genetics of Focal Epilepsy, S. F. Berkovic, P. Genton, E. Hirsch, and F. Picard (eds.), John Libby Co., London (1999), pp. 149-158.
23. T. Murase, K. Kondo, K. Otake, and Y. Oiso, "Pituitary adenylate cyclase-activating polypeptide stimulates arginine vasopressin release in conscious rats," Neuroendocrinology, 57, 1092-1096 (1993).
24. S. Nagaki, S. Nagaki, Y. Minatogawa, M. Sadamatsu, N. Kato, M. Osawa, and Y. Fukuyama, "The role of vasopressin, somatostatin, and GABA in febrile convulsion in rat pups, Life Sci., 58, 2233-2242 (1996).
25. M. Nomura, Y. Ueta, R. Serino, Y. Yamamoto, I. Shibuya, and H. Yamashita, Effects of centrally administered pituitary adenylate cyclase-activating polypeptide on c-fos gene expression and heteronuclear RNA for vasopressin in rat paraventricular and supraoptic nuclei," Neuroendocrinology, 69, 167-180 (1999).
26. Q. J. Pittman, A. Naylor, P. Poulin, J. Disturnal, W. L. Veale, S. M. Martin, T J. Malkinson, and B. Mathieson, "The role of vasopressin as an antipyretic in the ventral septal area and its possible involvement in convulsive disorders," Brain Res. Bull., 20, 887-892 (1988).
27. S. Shioda, T. Yada, S. Nakajo, K. Nakaya, Y. Nakai, and A. Arimura, "Pituitary adenylate cyclase-activating polypeptide (PACAP): a novel regulator of vasopressin-containing neurons," Brain Res., 765, 81-90 (1997).
28. N. Stella and P. J. Magistretti, "Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) potentiate the glutamate-evoked release of arachidonic acid from mouse cortical neurons. Evidence for a cAMP-independent mechanism," J. Biol. Chem., 271, 23705-23710 (1996).
29. C. G. Sweep and V. M. Wiegant, "Release of beta-endorphin-immunoreactivity from rat pituitary and hypothalamus in vitro: effects of isoproterenol, dopamine, corticotropin-releasing factor and arginine-8-vasopressin," Biochem. Biophys. Res. Commun., 161, 221-228 (1989).
30. W. L. Veale, K. E. Cooper, and W. D. Ruwe, "Vasopressin: its role in antipyresis and febrile convulsion", Brain Res. Bull., 12, 161-165 (1984).
31. L. Velisek, H. Kubova, M. Pohl, L. Stankova, P. Mares, and R. Schikverova, "Pentylenetetrazol-induced seizures in rats: an ontogenetic study," Naunyn Schmiedebergs Arch. Pharmacol., 346, 588-591 (1992).
32. B. J. Wilcox, P. Poulin, W. L. Veale, and Q. J. Pittman, "Vasopressin-induced motor-effects: localization of a sensitive site in the amygdala," Brain Res., 596, 58-64 (1992).
33. Y. Z. Ziylan and N. Ates, "Age-related changes in regional patterns of blood-brain barrier during epileptiform seizures induced by pentylenetrazol," Neurosci. Lett., 96, 179-184 (1989).